Is cervical involvement a sign of incurable disease in cancer of the thoracic esophagus?  by unknown
Is cervical involvement a sign of incurable disease
in cancer of the thoracic esophagus?
To the Editor:
I read with great interest the article by Altorki and
Skinner,1 “Occult Cervical Nodal Metastases in Esopha-
geal Cancer: Preliminary Results of Three-Field Lymph-
adenectomy” and the editorial comment by Orringer.2
Among the noteworthy results described in this article was
the relatively high frequency of nodal involvement limited
to the neck: two of five patients with a solitary positive
node had cervical involvement. This suggests that meta-
static spread to the cervical nodes occurs at a relatively
early stage and that cervical nodes are the principal
regional lymph nodes of the thoracic esophagus. The
number of patients in their series was small. We, however,
have previously reported the same observation in a larger
number of patients and have obtained favorable outcomes
after aggressive operations in such patients.3 The article
by Altorki and Skinner is the first Western report on this
apparently singular characteristic of esophageal cancer.
Orringer regards cervical involvement as a sign of
systemic disease, given that this is the case in lung cancer.
He stated that frequent occurrence of unsuspected cervi-
cal metastases indicates the highly malignant nature of
cancer of the thoracic esophagus. However, almost all
patients with cervical involvement also have mediastinal
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and hilar involvement in lung cancer, whereas exclusive
cervical involvement is frequent in cancer of the thoracic
esophagus. Cervical involvement in lung cancer is com-
monly found in the supraclavicular lymph nodes, whereas
esophageal cancer more frequently metastasizes to the
recurrent nerve lymph nodes. The azygos nodes and
subaortic nodes are more frequently involved than cervi-
cal nodes in right and left lung cancer, respectively, but, in
advanced esophageal cancer, enlargement of these nodes
is less frequently found than cervical node enlargement.
We consider the lymphatic drainage systems of the tho-
racic esophagus and lung to be fundamentally different,
despite the thoracic esophagus being anatomically adja-
cent to the lung.
It has been established by anatomic investigations
that the esophagus has abundant intramural lymphatic
channels running in the longitudinal direction.4 There-
fore, it is reasonable to assume that cancer cells metas-
tasize directly to the extrathoracic lymph nodes adja-
cent to the proximal and distal ends of the esophagus
through this lymphatic pathway: to recurrent nerve
nodes and the pericardiac nodes. Most surgeons agree
that cervical lymph nodes are the first target of metas-
tasis from malignant tumors involving the cervical
esophagus, whereas the pericardiac lymph nodes are
the major drainage nodes of the gastric cardia. Cervical
and pericardiac nodes should also be regarded as
regional nodes of the thoracic esophagus. Although the
pericardiac nodes have been categorized into the re-
gional node group of the thoracic esophagus in the
International Union Against Cancer (UICC) TNM
system, cervical recurrent nerve lymph nodes are still
classified as distant nodes.
The benefit of cervical dissection should be evaluated
on the basis of survival outcomes. Although prospective
well-controlled trials are the gold standard for reaching
definitive conclusions, it would be very time consuming to
complete such multicenter trials and obtain meaningful
results because of difficulties with accurate preoperative
staging, marked variability in the spread of disease, and
inconsistencies among institutions in treatment quality.
Rapid progress in therapeutic technology during the trial
might obscure the difference. We previously reported that
about 40% of patients in whom involvement was limited
to the recurrent nerve nodes were alive 5 years postoper-
atively.3 Orringer suggested the possibility of biologic
difference between tumors in Western countries and
Japan. However, the frequency of nodal involvement in
our series (70%) was similar to the frequency in the
Altorki and Skinner’s series (73%). Even if a biologic
difference is a possibility, our retrospective results favor
the assumption that cervical node involvement is not
always an indicator of incurability in cancer of the thoracic
esophagus.
I am interested in reading Orringer’s scientific com-
ments on these subjects.
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